Background Anti–phospholipase A2 receptor (anti-PLA2R) is a promising biomarker for
diagnosis, activity evaluation, therapy monitoring, and prognostic estimation of primary …

Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Objective To compare the positive rate of anti-PLA2R antibodies in patients with primary
membranous nephropathy (PMN), secondary membranous nephropathy (SMN), and non …

Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary
membranous nephropathy (PMN). We assessed the relationship between the levels of anti …

Background The diagnostic performance of PLA2R and IgG subclass staining of kidney
biopsies relative to anti-PLA2R seropositivity in the differentiation of primary and secondary …

Introduction: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is highly specific for
primary membranous nephropathy (PMN). Here, we compare the diagnostic value of …

Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

Objectives This study aimed to establish time-resolved fluorescence immunoassays to
quantitatively detect the autoantibodies targeting different epitopes of M-type phospholipase …

Results Antibodies were detected in 12 patients (54.54%): diagnosed (n= 5) and monitor (n=
7). All of patients with exacerbated disease process in monitored group had positive test …

Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology
practice has not changed dramatically, with most nephrologists still relying on a kidney …